The IMA Group (IMA) announces the acquisition of Chicago Research Center (CRC), an independent, Chicago-based clinical research site. The addition further broadens the scope and reach of IMA Clinical Research, the company’s full-service, national network of sites supporting Phase II–IV clinical trials across multiple therapeutic areas. CRC is known for its expertise in Phase I–IV trials, focused on central nervous system (CNS), sleep disorders, mood and memory disorders, pain, and general medicine. The company operates a research sleep lab for dedicated use in insomnia, apnea, narcolepsy, restless leg and shift work sleep disorder clinical trials.
Read the full article: The IMA Group Clinical Research Division Continues Expansion with Acquisition of Chicago Research Center //
Source: https://www.businesswire.com/news/home/20251008953826/en/The-IMA-Group-Clinical-Research-Division-Continues-Expansion-with-Acquisition-of-Chicago-Research-Center